All Stories

  1. Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis
  2. Assessing Quality of Ultrasound Attenuation Coefficient Results for Liver Fat Quantification
  3. Ultrasound evaluation of chronic liver disease
  4. Understanding confounding factors allows for accurate interpretation of liver stiffness measurements by ElastQ, a novel 2D shear wave elastography technique
  5. Letter to the Editor: “Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound”
  6. Editorial Comment: A Step Toward the Clinical Application of Quantitative Ultrasound in the Diagnosis of Steatotic Liver Disease
  7. Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth
  8. Editorial: ARFI‐based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity
  9. WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography
  10. Ultrasound-based steatosis grading system using 2D-attenuation imaging: An individual patient data meta-analysis with external validation
  11. Does Meal or Water Intake Affect Ultrasound Attenuation Coefficient Estimate?
  12. WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification
  13. Recent advances in noninvasive assessment of liver steatosis
  14. MR and Ultrasound Elastography for Fibrosis Assessment in Children: Practical Implementation and Supporting Evidence—AJR Expert Panel Narrative Review
  15. Two-dimensional shear wave elastography (ElastQ) accurately rules out liver fibrosis and rules in advanced chronic liver disease across liver disease etiologies: a prospective multicenter study
  16. Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging
  17. Diffuse liver disease: the new horizon of multiparametric ultrasound
  18. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists
  19. Liver Fat Quantification With Ultrasound
  20. Interpreting shear wave elastography results in chronic hepatitis D virus infection
  21. Interpreting Liver Stiffness Values in Clinical Practice: Is Histologic Classification Necessary for Clinical Relevance?
  22. Quantification of Liver Fat Content with the iATT Algorithm: Correlation with Controlled Attenuation Parameter
  23. How to perform shear wave elastography. Part II
  24. US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative
  25. Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography
  26. How to perform shear wave elastography. Part I
  27. Update on the role of elastography in liver disease
  28. 2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting
  29. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper
  30. Beyond the AJR: “Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease”
  31. Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
  32. A model to predict liver damage in patients with HBeAg-positive chronic HBV infection
  33. What does liver elastography measure? Technical aspects and methodology
  34. Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
  35. CAP for the detection of hepatic steatosis in clinical practice
  36. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis
  37. Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study
  38. SIUMB recommendations for focal pancreatic lesions
  39. Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion
  40. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement
  41. Ultrasound liver elastography beyond liver fibrosis assessment
  42. Performance and cutoffs for liver fibrosis staging of a two-dimensional shear wave elastography technique
  43. Ultrasound-based techniques for the diagnosis of liver steatosis
  44. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique
  45. General advice in ultrasound based elastography of pediatric patients
  46. Point shear wave elastography by ElastPQ accurately stages hepatic fibrosis in patients with NAFLD: A prospective, multicentric study
  47. Ultrasound Techniques for the Assessment of Liver Stiffness: A Correct Terminology
  48. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations
  49. Review of Liver Elastography Guidelines
  50. Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment—A multicenter retrospective study
  51. Current Knowledge in Ultrasound-Based Liver Elastography of Pediatric Patients
  52. Evaluation of Inter-System Variability in Liver Stiffness Measurements
  53. Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
  54. Editorial: a novel technology for the assessment of non-alcoholic fatty liver disease
  55. Novel ultrasound-based methods to assess liver disease: The game has just begun
  56. Contrast-enhanced ultrasonography of the liver using SonoVue
  57. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis
  58. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
  59. Ruling-in and Ruling-out Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C Using a Shear Wave Measurement Method
  60. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
  61. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
  62. Limitations and artifacts in shear-wave elastography of the liver
  63. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
  64. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version)
  65. Shear wave elastography of the liver – review on normal values
  66. Ruling-in and ruling-out significant fibrosis and cirrhosis using a shear wave measurement method
  67. Impact of hepatic steatosis and controlled attenuation parameter (CAP) on accuracy of fibrosis staging using transient elastography
  68. The clinical value of the controlled attenuation parameter in the follow-up of HIV-infected patients
  69. Accuracy of the ElastPQ® Technique for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C: a “Real Life” Single Center Study
  70. The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis
  71. Elastography Assessment of Liver Fibrosis
  72. Liver stiffness assessed by transient elastography in patients with β thalassaemia major
  73. Accuracy of the latest release of a 2D shear wave elastography method for staging liver fibrosis in patients with chronic hepatitis C: Preliminary results
  74. Consensus on Elastography of the Liver
  75. Accuracy of the Latest Release of a Point Shear Wave Elastography Method for Staging Liver Fibrosis in Patients with Chronic Hepatitis C
  76. Noninvasive Assessment of Liver Fibrosis and Steatosis in HIV-Monoinfected Subjects
  77. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection
  78. A Review of the Appropriateness of the Current Italian Guidelines for Noninvasive Imaging Assessment of Focal Liver Lesions
  79. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement
  80. Contrast enhanced ultrasound in the evaluation and percutaneous treatment of hepatic and renal tumors
  81. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast
  82. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver
  83. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 1: Basic Principles and Terminology
  84. O018 : 2D-shear wave elastography is equivalent or superior to transient elastography for liver fibrosis assessment: Results from an individual patient data based meta-analysis
  85. P1008 : Value of controlled attenuation parameter (CAP) in the clinical practice: preliminary results
  86. Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals
  87. Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis
  88. Ultrasound point shear wave elastography assessment of liver and spleen stiffness: effect of training on repeatability of measurements
  89. Shear Wave Elastography for Evaluation of Liver Fibrosis
  90. Point shear wave elastography method for assessing liver stiffness
  91. Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis
  92. Volume Responsiveness in Critically Ill Patients
  93. Real-time tissue elastography in the assessment of liver stiffness
  94. 16 PERFORMANCE OF ELASTPQ® SHEAR WAVE ELASTOGRAPHY TECHNIQUE FOR ASSESSING FIBROSIS IN CHRONIC VIRAL HEPATITIS
  95. Performance of liver stiffness measurements by transient elastography in chronic hepatitis
  96. Cat-scratch disease in Northern Italy: atypical clinical manifestations in humans and prevalence of Bartonella infection in cats
  97. Reproducibility of real-time shear wave elastography in the evaluation of liver elasticity
  98. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study
  99. Performance of Real-Time Strain Elastography, Transient Elastography, and Aspartate-to-Platelet Ratio Index in the Assessment of Fibrosis in Chronic Hepatitis C
  100. Assessment of liver stiffness with transient elastography by using S and M probes in healthy children
  101. 1052 PERFORMANCE OF REAL-TIME STRAIN ELASTOGRAPHY, SHEAR WAVE ELASTOGRAPHY, AND TRANSIENT ELASTOGRAPHY IN ASSESSING SIGNIFICANT FIBROSIS IN CHRONIC VIRAL HEPATITIS
  102. Arterial Stiffness Evaluation in HIV-Positive Patients: A Multicenter Matched Control Study
  103. Accuracy of Ultrasound Imaging Technique for Assessing Lipoatrophy in HIV-Infected Subjects
  104. Italian guidelines for noninvasive imaging assessment of focal liver lesions
  105. Retroperitoneal Cryptococcoma in a Case of Disseminated Cryptococcosis on Antifungal Maintenance Therapy
  106. Management of splenic abscess: report on 16 cases from a single center
  107. Follow-Up After Percutaneous Radiofrequency Ablation of Renal Cell Carcinoma: Contrast-Enhanced Sonography Versus Contrast-Enhanced CT or MRI
  108. Contrast-Enhanced Ultrasonographic Findings in a Brucellar Hepatic Abscess
  109. Titelbild - Große intrahepatische arterioportale Fistel nach Lebertrauma
  110. Percutaneous and surgical treatment of pyogenic liver abscesses: Observation over a 21-year period in 148 patients
  111. Comparability of Echographic and Tomographic Assessments of Body Fat Changes Related to the HIV Associated Adipose Redistribution Syndrome (HARS) in Antiretroviral Treated Patients
  112. Open Questions in the Assessment of Liver Fibrosis Using Real-Time Elastography
  113. Sonographic Training Program at a District Hospital in a Developing Country: Work in Progress
  114. Real-Time Elastography in the Assessment of Liver Fibrosis
  115. Percutaneous Needle Aspiration of Multiple Pyogenic Abscesses of the Liver: 13-Year Single-Center Experience
  116. Ärztliche Assistenz zur Selbsttötung - ethische, rechtliche und klinische Aspekte - Erwiderung
  117. The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations
  118. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy
  119. Liver Abscess Formation After Radiofrequency Ablation in Patients with Hepatocellular Carcinoma
  120. Contrast-Enhanced Low-Mechanical-Index Ultrasonography in Hepatic Splenosis
  121. Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center
  122. Contrast-Enhanced Sonographic Appearance of Hepatocellular Carcinoma in Patients with Cirrhosis: Comparison with Contrast-Enhanced Helical CT Appearance
  123. Radiofrequency Thermal Ablation versus Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma [letter]
  124. Acute Appendicitis Mimicking Infectious Enteritis
  125. Percutaneous Sonographically Guided Saline-Enhanced Radiofrequency Ablation of Hepatocellular Carcinoma
  126. Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery.
  127. Interobserver and interquipment variability of echo-doppler examination of the portal vein: Effect of a cooperative training program
  128. Interobserver and interequipment variability of echo-doppler examination of the portal vein: Effect of a cooperative training program
  129. Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: A double-blind randomized echo-doppler study
  130. Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: A double-blind randomized echo-doppler study*1
  131. Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study
  132. Operators, machines, and a time interval variability of Echo-Doppler flowmetry for splanchnic hemodynamics
  133. Echo-Doppler evaluation of acute flow changes in portal hypertensive patients: flow velocity as a reliable parameter
  134. A Randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients
  135. Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: An operator-blind echo-Doppler study
  136. Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: An operator-blind echo-Doppler study
  137. Feasibility spectrum for Doppler flowmetry of splanchnic vessels. In normal and cirrhotic populations.
  138. Bile acids do not mediate the hyperdynamic circulation in portal hypertensive rats
  139. Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers